Legal & General Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Legal & General Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-560	Closed	-$7K	–	3426
2019 Q2	$7K	Hold	560	–	–	﹤0.01%	3421
2019 Q1	$10K	Hold	560	–	–	﹤0.01%	3251
2018 Q4	$8K	Hold	560	–	–	﹤0.01%	3292
2018 Q3	$12K	Hold	560	–	–	﹤0.01%	3306
2018 Q2	$24K	Sell	560 -10	-2%	-$458	﹤0.01%	3117
2018 Q1	$37K	Sell	570 -232	-29%	-$16.4K	﹤0.01%	2897
2017 Q4	$59K	Buy	802 +201	+33%	+$16.6K	﹤0.01%	2818
2017 Q3	$55K	Hold	601	–	–	﹤0.01%	2884
2017 Q2	$39K	Hold	601	–	–	﹤0.01%	2980
2017 Q1	$130K	Hold	601	–	–	﹤0.01%	2419
2016 Q4	$55K	Buy	601 +198	+49%	+$22.3K	﹤0.01%	2863
2016 Q3	$53K	Hold	403	–	–	﹤0.01%	2500
2016 Q2	$39K	Hold	403	–	–	﹤0.01%	2601
2016 Q1	$65K	Sell	403 -2	-0.5%	-$405	﹤0.01%	2301
2015 Q4	$131K	Hold	405	–	–	﹤0.01%	1931
2015 Q3	$131K	Hold	405	–	–	﹤0.01%	1895
2015 Q2	$160K	Hold	405	–	–	﹤0.01%	1842
2015 Q1	$205K	Hold	405	–	–	﹤0.01%	1672
2014 Q4	$145K	Sell	405 -35	-8%	-$10.4K	﹤0.01%	1750
2014 Q3	$89K	Buy	+440	New	+$96.7K	﹤0.01%	1972

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Legal & General Group's LUMO Position: Q3 2019 in Review

Legal & General Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 560 shares — an estimated $7K sold.

Legal & General Group first reported a position in LUMO in Q3 2014 and held it in 20 quarters. The position peaked at $205K in Q1 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

Legal & General Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Legal & General Group sold 560 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $7K.
Legal & General Group first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2014 and held it in 20 quarters.
Legal & General Group's Lumos Pharma, Inc. Common Stock position peaked at $205K in Q1 2015.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.